Results 1 to 10 of about 4,595,974 (209)
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs [PDF]
Российский кардиологический журнал, 2021 The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +2 more sources
Reversal of direct oral anticoagulants
Vascular Health and Risk Management, 2017 Mosaad Almegren Department of Medicine, Al Imam Mohammad Ibn Saud Islamic University, Riyadh, Kingdom of Saudi Arabia Abstract: Reversal agents for direct oral anticoagulants (DOACs), including factor X inhibitors and direct thrombin inhibitors, are a ...
Almegren M
doaj +3 more sources
Direct-acting oral anticoagulants in antiphospholipid syndrome [PDF]
Научно-практическая ревматология, 2021 Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid ...
T. M. Reshetnyak, K. S. Nurbaeva
doaj +2 more sources
Direct oral anticoagulants and venous thromboembolism [PDF]
European Respiratory Review, 2016 Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary embolism, is a major clinical concern associated with significant morbidity and mortality.
Massimo Franchini +1 more
doaj +2 more sources
Direct oral anticoagulants. The story of success
Cardiologia HungaricaLets organize a nice funeral for warfarin – told by Eugene Braunwald twenty years ago, when first large scale studies had been planned and started with direct oral anticoagulants (DOACs), earlier called novel oral anticoagulants (NOACS).
Róbert Gábor Kiss
doaj +2 more sources
Interdisciplinary Neurosurgery, 2018 Direct oral anticoagulants are becoming more commonplace for the treatment of nonvalvular atrial fibrillation and deep vein thrombosis. Unfortunately, effective reversal agents are not widely available limiting options for neurosurgical intervention ...
Joseph H. McMordie, MD +3 more
doaj +2 more sources
Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review
Рациональная фармакотерапия в кардиологии, 2022 The last decade has dramatically changed the strategy of anticoagulant therapy in patients with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct thrombin blockers (dabigatran) or factor IIa blockers ...
B. A. Tatarsky, N. V. Kazennova
doaj +1 more source
Frontiers in Pharmacology, 2023 Objectives: Our objective was to analyse effectiveness and safety of oral anticoagulants (OAC) for stroke prevention in non-valvular atrial fibrillation.Material and methods: Population-based cohort study including adults initiating oral anticoagulants ...
Maria Giner-Soriano +18 more
doaj +1 more source
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
Рациональная фармакотерапия в кардиологии, 2021 Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other and contribute to worsening prognosis. Both atrial fibrillation and chronic kidney disease are associated with increased risk of stroke and thromboembolic ...
Z. D. Kobalava +2 more
doaj +1 more source
Direct oral anticoagulants for electrical cardioversion
Кардиоваскулярная терапия и профилактика, 2021 The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using
A. N. Volovchenko +2 more
doaj +1 more source